Cited 0 times in Scipus Cited Count

An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases

DC Field Value Language
dc.contributor.authorPiracha, ZZ-
dc.contributor.authorSaeed, U-
dc.contributor.authorKim, J-
dc.contributor.authorKwon, H-
dc.contributor.authorChwae, YJ-
dc.contributor.authorLee, HW-
dc.contributor.authorLim, JH-
dc.contributor.authorPark, S-
dc.contributor.authorShin, HJ-
dc.contributor.authorKim, K-
dc.date.accessioned2022-10-28T05:28:55Z-
dc.date.available2022-10-28T05:28:55Z-
dc.date.issued2020-
dc.identifier.issn0022-538X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/22468-
dc.description.abstractSirtuin 2 (Sirt2), an NAD(+)-dependent protein deacetylase, deacetylates tubulin, AKT, and other proteins. Previously, we showed that Sirt2 isoform 1 (Sirt2.1) increased replication of hepatitis B virus (HBV). Here, we show that HBV replication upregulates the expression of Sirt2 primary and alternatively spliced transcripts and their respective isoforms, 1, 2, and 5. Since Sirt2 isoform 5 (Sirt2.5) is a catalytically inactive nuclear protein with a spliced-out nuclear export signal (NES), we speculated that its different localization affects its activity. The overexpression of Sirt2.5 reduced expression of HBV mRNAs, replicative intermediate DNAs, and covalently closed circular DNA (cccDNA), an activity opposite that of Sirt2.1 and Sirt2.2. Unlike the Sirt2.1-AKT interaction, the Sirt2.5-AKT interaction was weakened by HBV replication. Unlike Sirt2.1, Sirt2.5 activated the AKT/GSK-3beta/beta-catenin signaling pathway very weakly and independently of HBV replication. When the NES and an N-terminal truncated catalytic domain were added to the Sirt2.5 construct, it localized in the cytoplasm and increased HBV replication (like Sirt2.1 and Sirt2.2). Chromatin immunoprecipitation assays revealed that more Sirt2.5 was recruited to cccDNA than Sirt2.1. The recruitment of histone lysine methyltransferases (HKMTs), such as SETDB1, SUV39H1, EZH2, and PR-Set7, and their respective transcriptional repressive markers, H3K9me3, H3K27me3, and H4K20me1, to cccDNA also increased in Sirt2.5-overexpressing cells. Among these, the Sirt2.5-PR-Set7 and -SETDB1 interactions increased upon HBV replication. These results demonstrate that Sirt2.5 reduces cccDNA levels and viral transcription through epigenetic modification of cccDNA via direct and/or indirect association with HKMTs, thereby exhibiting anti-HBV activity.IMPORTANCE Sirt2, a predominant cytoplasmic alpha-tubulin deacetylase, promotes the growth of hepatocellular carcinoma; indeed, HBV replication increases Sirt2 expression, and overexpression of Sirt2 is associated with hepatic fibrosis and epithelial-to-mesenchymal transition. Increased amounts of Sirt2 isoforms 1, 2, and 5 upon HBV replication might further upregulate HBV replication, leading to a vicious cycle of virus replication/disease progression. However, we show here that catalytically inactive nuclear Sirt2.5 antagonizes the effects of Sirt2.1 and Sirt2.2 on HBV replication, thereby inhibiting cccDNA level, transcription of cccDNA, and subsequent synthesis of replicative intermediate DNA. More Sirt2.5 was recruited to cccDNA than Sirt2.1, thereby increasing epigenetic modification by depositing transcriptional repressive markers, possibly through direct and/or indirect association with histone lysine methyltransferases, such as SETDB1, SUV39H1, EZH2, and/or PR-Set7, which represses HBV transcription. Thus, Sirt2.5 might provide a functional cure for HBV by silencing the transcription of HBV.-
dc.language.isoen-
dc.subject.MESHAlternative Splicing-
dc.subject.MESHCell Line, Tumor-
dc.subject.MESHDNA, Circular-
dc.subject.MESHDNA, Viral-
dc.subject.MESHEpigenesis, Genetic-
dc.subject.MESHEpigenetic Repression-
dc.subject.MESHHepatitis B-
dc.subject.MESHHepatitis B virus-
dc.subject.MESHHistone-Lysine N-Methyltransferase-
dc.subject.MESHHistones-
dc.subject.MESHHumans-
dc.subject.MESHProtein Isoforms-
dc.subject.MESHSirtuin 2-
dc.subject.MESHTranscription, Genetic-
dc.subject.MESHTranscriptional Activation-
dc.subject.MESHVirus Replication-
dc.titleAn Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases-
dc.typeArticle-
dc.identifier.pmid32493816-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394897/-
dc.subject.keywordepigenetic modifications-
dc.subject.keywordhistone lysine methyltransferases-
dc.subject.keywordSirt2 isoform 5-
dc.subject.keywordcccDNA-
dc.subject.keywordhepatitis B virus-
dc.contributor.affiliatedAuthorPiracha, ZZ-
dc.contributor.affiliatedAuthorChwae, YJ-
dc.contributor.affiliatedAuthorPark, S-
dc.contributor.affiliatedAuthorShin, HJ-
dc.contributor.affiliatedAuthorKim, K-
dc.type.localJournal Papers-
dc.identifier.doi10.1128/JVI.00926-20-
dc.citation.titleJournal of virology-
dc.citation.volume94-
dc.citation.number16-
dc.citation.date2020-
dc.citation.startPagee00926-20-
dc.citation.endPagee00926-20-
dc.identifier.bibliographicCitationJournal of virology, 94(16). : e00926-20-e00926-20, 2020-
dc.identifier.eissn1098-5514-
dc.relation.journalidJ00022538X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Microbiology
Files in This Item:
32493816.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse